NCT04354987View on ClinicalTrials.gov

Compare the Pharmacokinetics and Safety of CKD-391

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

January 9, 2020

Study Completion Date

January 9, 2020

Conditions
Hyperlipidemias
Interventions
DRUG

CKD-391 10/10mg

Drug T: CKD-391 10/10mg(Other Name: Test Drug)

DRUG

D090, D337

D090 and D337 co-administration(Other Name: Reference drug)

Trial Locations (1)

463-707

Jae-Yong Chung, Gyeonggi-do

Sponsors
All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04354987 - Compare the Pharmacokinetics and Safety of CKD-391 | Biotech Hunter | Biotech Hunter